Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1981 1
1982 1
1984 1
1986 1
1987 2
1988 6
1989 1
1990 9
1991 8
1992 7
1993 1
1994 4
1995 7
1996 4
1998 2
2000 2
2001 1
2002 1
2003 1
2004 1
2006 1
2007 2
2009 10
2010 13
2011 8
2012 7
2013 7
2014 6
2015 7
2016 6
2017 10
2018 6
2019 11
2020 14
2021 15
2022 8
2023 14
2024 13
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sugiura I, Doki N, Hata T, Cho R, Ito T, Suehiro Y, Tanaka M, Kako S, Matsuda M, Yokoyama H, Ishikawa Y, Taniguchi Y, Hagihara M, Ozawa Y, Ueda Y, Hirano D, Sakura T, Tsuji M, Kamae T, Fujita H, Hiramoto N, Onoda M, Fujisawa S, Hatta Y, Dobashi N, Nishiwaki S, Atsuta Y, Kobayashi Y, Hayakawa F, Ohtake S, Naoe T, Miyazaki Y. Sugiura I, et al. Among authors: nishiwaki s. Blood Adv. 2022 Jan 25;6(2):624-636. doi: 10.1182/bloodadvances.2021004607. Blood Adv. 2022. PMID: 34516628 Free PMC article. Clinical Trial.
Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial.
Shimoi T, Sunami K, Tahara M, Nishiwaki S, Tanaka S, Baba E, Kanai M, Kinoshita I, Shirota H, Hayashi H, Nishida N, Kubo T, Mamesaya N, Ando Y, Okita N, Shibata T, Nakamura K, Yamamoto N. Shimoi T, et al. Among authors: nishiwaki s. EClinicalMedicine. 2024 Feb 2;69:102447. doi: 10.1016/j.eclinm.2024.102447. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38333370 Free PMC article.
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, Kurahashi S, Ueda Y, Dobashi N, Maeda T, Matsumura I, Tanaka M, Kako S, Ichinohe T, Fukuda T, Ohtake S, Ishikawa Y, Miyazaki Y, Kiyoi H; Japan Adult Leukemia Study Group. Nishiwaki S, et al. Am J Hematol. 2024 May;99(5):806-815. doi: 10.1002/ajh.27237. Epub 2024 Feb 5. Am J Hematol. 2024. PMID: 38314662
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ishida H, Arakawa Y, Hasegawa D, Usami I, Hashii Y, Arai Y, Nishiwaki S, Keino D, Kato K, Sato M, Yoshida N, Ozawa Y, Okada K, Hidaka M, Yuza Y, Tanaka M, Watanabe K, Takita J, Kosaka Y, Fujita N, Tanaka J, Sato A, Atsuta Y, Imamura T. Ishida H, et al. Among authors: nishiwaki s. Ann Hematol. 2024 Mar;103(3):843-854. doi: 10.1007/s00277-023-05557-z. Epub 2023 Nov 25. Ann Hematol. 2024. PMID: 38006571
Anticarcinogenic effects of (-)-epigallocatechin gallate.
Fujiki H, Yoshizawa S, Horiuchi T, Suganuma M, Yatsunami J, Nishiwaki S, Okabe S, Nishiwaki-Matsushima R, Okuda T, Sugimura T. Fujiki H, et al. Among authors: nishiwaki s. Prev Med. 1992 Jul;21(4):503-9. doi: 10.1016/0091-7435(92)90057-o. Prev Med. 1992. PMID: 1409491 Review.
Efficacy and safety of Saireito (TJ-114) in patients with atrial fibrillation undergoing catheter ablation procedures: A randomized pilot study.
Kawaji T, Shizuta S, Yaku H, Kaneda K, Yoneda F, Nishiwaki S, Tanaka M, Aizawa T, Hojo S, Nakatsuma K, Kato M, Yokomatsu T, Miki S, Ono K, Kimura T. Kawaji T, et al. Among authors: nishiwaki s. PLoS One. 2024 Aug 1;19(8):e0307854. doi: 10.1371/journal.pone.0307854. eCollection 2024. PLoS One. 2024. PMID: 39088481 Free PMC article. Clinical Trial.
Determinant analysis of IgE and IgG4 antibodies and T cells specific for bovine alpha(s)1-casein from the same patients allergic to cow's milk: existence of alpha(s)1-casein-specific B cells and T cells characteristic in cow's-milk allergy.
Nakajima-Adachi H, Hachimura S, Ise W, Honma K, Nishiwaki S, Hirota M, Shimojo N, Katsuki T, Ametani A, Kohno Y, Kaminogawa S. Nakajima-Adachi H, et al. Among authors: nishiwaki s. J Allergy Clin Immunol. 1998 May;101(5):660-71. doi: 10.1016/s0091-6749(98)70175-7. J Allergy Clin Immunol. 1998. PMID: 9600504
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study.
Minakata D, Uchida T, Nakano A, Takase K, Tsukada N, Kosugi H, Kawata E, Nakane T, Takahashi H, Endo T, Nishiwaki S, Fujiwara H, Saito AM, Saito TI, Akashi K, Matsumura I, Mitani K. Minakata D, et al. Among authors: nishiwaki s. Int J Hematol. 2024 Feb;119(2):183-195. doi: 10.1007/s12185-023-03685-w. Epub 2024 Jan 3. Int J Hematol. 2024. PMID: 38172385 Free PMC article.
198 results